MarketBeat reported a Moderate Buy consensus rating for Genelux, while Benchmark reissued a speculative buy rating, and an insider sold shares.
1 report, 1 independent
Updated Sep 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat reported a Moderate Buy consensus rating for Genelux, while Benchmark reissued a speculative buy rating, and an insider sold shares.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Genelux Corporation
biopharmaceutical company
Nothing else this week.
-
MarketBeat
American personal finance blog
-
Benchmark
venture capital firm
- The Bank of England, FED, and market experts are discussing how the ongoing Iran conflict and geopolitical tensions are driving up energy costs and influencing global financial rates.
- MarketBeat published a buy rating and target price increase for a company, with disclosures made under a Rule 10b5-1 trading plan.
Related events
- MarketBeat reported recent stock ratings for Innovative Solutions and Support, Inc. and TechPrecision Corporation.
- MarketBeat reported the stock consensus rating for Phunware on September 8, 2026.
- MarketBeat reported consensus ratings and Benchmark reiterated a hold rating for Dine Brands Global.
- MarketBeat provided consensus rating data and insider trading was disclosed via SEC filing for Bay Commercial Bank.
- MarketBeat reported an average stock rating for Superior Group of Companies.